Phase 4 Psoriasis Trial, Recruiting (NCT05390515)

Phase 4 Psoriasis Trial, Recruiting NCT05390515 Sponsor: University of California, San Francisco Condition: Psoriasis

Printed from Voxsanity (voxsanity.com.au) — NCT05390515 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Psoriasis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with moderate to severe psoriasis, or psoriasis that affects more than 5% of your body surface area

Who may not be able to join:

You have taken medicines that suppress the immune system (such as certain tablets or injections) in the last 4 weeks
You are currently pregnant
You have a serious condition that severely weakens your immune system, whether from a genetic condition or an infection (such as HIV/AIDS)
You currently have tuberculosis (TB) or another serious active infection
You currently have an active cancer that has spread to other parts of your body
You are currently breastfeeding
You have any other condition or health problem that the trial doctor believes could put your safety at risk or affect the reliability of the trial results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Raymond Cho, MD, PhD, University of California, San Francisco

Phone: 415-575-0524

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05390515

Sponsor: University of California, San Francisco

Phase: Phase 4

Status: Recruiting

Condition: Psoriasis

Trial contact: 415-575-0524

More information: https://clinicaltrials.gov/study/NCT05390515

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with moderate to severe psoriasis, or psoriasis that affects more than 5% of your body surface area

Who may not be able to join:

You have taken medicines that suppress the immune system (such as certain tablets or injections) in the last 4 weeks
You are currently pregnant
You have a serious condition that severely weakens your immune system, whether from a genetic condition or an infection (such as HIV/AIDS)
You currently have tuberculosis (TB) or another serious active infection
You currently have an active cancer that has spread to other parts of your body
You are currently breastfeeding
You have any other condition or health problem that the trial doctor believes could put your safety at risk or affect the reliability of the trial results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

1 September 2022

Est. completion

1 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Psoriasis Area and Severity Index (PASI) Score at baseline and 3 months of treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov